Opportunity Information: Apply for PAR 18 251

The grant opportunity titled "Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)" (Funding Opportunity Number: PAR 18-251) is a National Institutes of Health (NIH) discretionary grant focused on reducing smoking-related health disparities. The central goal is to support intervention research that can meaningfully improve smoking cessation outcomes specifically among socioeconomically disadvantaged groups, recognizing that these populations often face higher tobacco use rates, lower quit success, and greater barriers to accessing effective treatment. The announcement emphasizes that funded projects should not only be innovative, but also realistic to scale so they can reach large numbers of people and create broad public health impact rather than remaining limited to small, resource-intensive programs.

A key theme of the FOA is the dual requirement that proposed interventions be (1) targeted to socioeconomically disadvantaged populations and (2) designed with scalability in mind. In practice, this means applicants are encouraged to design cessation strategies that fit the real-world contexts in which disadvantaged smokers live and seek care, such as safety-net clinics, community health settings, public housing environments, community-based organizations, and other systems that serve low-income or underserved communities. The FOA is open to a wide range of approaches, including the development and testing of novel smoking cessation interventions that could be expanded to broad populations, as well as projects that improve existing cessation programs that are already scaled or widely available. For example, applicants could propose ways to enhance the effectiveness, quality, accessibility, utilization, or cost-effectiveness of established interventions, including improving engagement, adherence, reach, or outcomes in disadvantaged groups.

The opportunity also makes clear that projects may include clinical trials, but they are not required, as reflected by the "Clinical Trial Optional" designation. This allows applicants to propose the most appropriate study design for their stage of research and the intervention being tested, ranging from early-phase development and optimization work to more definitive testing, implementation-oriented studies, or effectiveness-focused trials. Importantly, the FOA supports up to five years of funding, and it explicitly allows time and resources not just for the intervention itself, but also for research planning, intervention delivery, and follow-up activities. That structure signals interest in well-designed studies that can capture meaningful cessation outcomes over time and evaluate whether effects are durable rather than short-lived.

Eligibility is broad, reflecting an interest in bringing in diverse institutions and community partners that are positioned to reach disadvantaged populations. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses, among others. The FOA also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. (foreign) entities. This broad eligibility aligns with the FOA's emphasis on scalable impact and reaching communities that have historically been underserved.

Administratively, the funding instrument is an NIH R01 research project grant under CFDA 93.399, categorized under education and health. The posting indicates an original closing date of June 13, 2019, and a creation date of November 30, 2017. While the summary does not list a specific award ceiling or the expected number of awards, the core purpose is clearly defined: to generate scalable, high-impact cessation interventions that can reduce tobacco-related inequities by improving quit outcomes among socioeconomically disadvantaged populations, either through new intervention development or by strengthening and adapting interventions that already operate at scale.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.399.
  • This funding opportunity was created on 2017-11-30.
  • Applicants must submit their applications by 2019-06-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 251

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Previous opportunity: Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 251

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 251) also looked into and applied for these:

Funding Opportunity
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 18 222

Funding Number: PAR 18 222
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 18 226

Funding Number: PAR 18 226
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) Apply for PA 18 379

Funding Number: PA 18 379
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Apply for PAR 18 476

Funding Number: PAR 18 476
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Cancer Research Education Grants Program - Research Experiences (R25) Apply for PAR 18 478

Funding Number: PAR 18 478
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Research Education Grants Program - Courses for Skills Development (R25) Apply for PAR 18 477

Funding Number: PAR 18 477
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) Apply for RFA DA 18 019

Funding Number: RFA DA 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Apply for PAR 18 467

Funding Number: PAR 18 467
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Apply for PAR 18 466

Funding Number: PAR 18 466
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Apply for PA 18 492

Funding Number: PA 18 492
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Apply for PA 18 493

Funding Number: PA 18 493
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional) Apply for RFA DA 19 002

Funding Number: RFA DA 19 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $3,000,000
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional) Apply for PA 18 498

Funding Number: PA 18 498
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) Apply for PAR 18 494

Funding Number: PAR 18 494
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) Apply for PA 18 499

Funding Number: PA 18 499
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Apply for PA 18 503

Funding Number: PA 18 503
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) Apply for PA 18 502

Funding Number: PA 18 502
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Apply for PAR 18 434

Funding Number: PAR 18 434
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional) Apply for PA 18 347

Funding Number: PA 18 347
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed) Apply for PA 18 473

Funding Number: PA 18 473
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 251", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: